NPI: 1629030432 · LANCASTER, PA 17602 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/05/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP L & C DEPARTMENT) |
| NPI Enumeration Date | 04/05/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,061 | $0.00 |
| 2019 | 8,230 | $270.75 |
| 2020 | 2,431 | $109K |
| 2021 | 4,066 | $272K |
| 2022 | 4,459 | $366K |
| 2023 | 5,124 | $581K |
| 2024 | 4,032 | $536K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 22,866 | 1,910 | $1.86M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 5,609 | 370 | $270.75 |
| 83970 | 245 | 191 | $0.00 | |
| 85041 | 467 | 440 | $0.00 | |
| 83540 | 399 | 373 | $0.00 | |
| 85048 | 467 | 440 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 297 | 85 | $0.00 |
| 82108 | 31 | 31 | $0.00 | |
| 83550 | 398 | 373 | $0.00 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,752 | 364 | $0.00 |
| A4657 | Syringe, with or without needle, each | 1,542 | 866 | $0.00 |
| 82728 | 174 | 159 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 61 | 31 | $0.00 |
| 82746 | 30 | 30 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 35 | 12 | $0.00 |
| 82607 | 30 | 30 | $0.00 |